FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065727097> ?p ?o ?g. }

• W2065727097 endingPage "1216" @default.
• W2065727097 startingPage "1209" @default.
• W2065727097 abstract "Objective. This study was conducted to investigate the efficacy and safety of gabapentin monotherapy in the management of chemotherapy-induced neuropathic pain. Patients. Seventy-five cancer patients who had previously received chemotherapy, and had experienced at least one symptom of neuropathic pain were included in the intervention group. They received a fixed low-dose of gabapentin (800 mg/day). The control group consisted of 35 cancer patients with similar treatment history and symptomatology, who refused treatment with gabapentin and, therefore, received a fixed-dose combination of naproxen and codeine/paracetamol. Outcome Measures. Patients were grouped in three categories according to the severity of their neuropathic symptoms at baseline: mild, moderate, and severe. Analgesic efficacy of the study drug was assessed by means of a patient-answered questionnaire. Four stages of analgesic response were established: complete, partial, minor, and no response. Results. All patients completed the study and were evaluable. In the intervention arm, gabapentin led to a complete response in 25.3% of patients (19/75), partial response in 44% (33/75), minor response in 25.3% (19/75), and no response in 5.3% (4/75). The response to gabapentin correlated with the severity of the underlying neurotoxicity. Approximately 25% of patients receiving gabapentin experienced mild somnolence, but none discontinued it. In the control group, none experienced complete response (0/35), while partial, minor, and no response were observed in 5.7% (2/35), 45.7% (16/35), and 48.6% (17/35), respectively. Compared with the control group, gabapentin therapy led to a statistically significant better response in patients of each baseline neurotoxicity group. Conclusions. Gabapentin monotherapy seems to be well tolerated and useful for the management of chemotherapy-induced neuropathic pain." @default.
• W2065727097 created "2016-06-24" @default.
• W2065727097 creator A5013146986 @default.
• W2065727097 creator A5034903945 @default.
• W2065727097 creator A5035246805 @default.
• W2065727097 creator A5054603036 @default.
• W2065727097 creator A5064667083 @default.
• W2065727097 creator A5067076091 @default.
• W2065727097 creator A5068715872 @default.
• W2065727097 creator A5072956257 @default.
• W2065727097 creator A5086520966 @default.
• W2065727097 creator A5089910357 @default.
• W2065727097 date "2008-11-01" @default.
• W2065727097 modified "2023-10-14" @default.
• W2065727097 title "Gabapentin Monotherapy for the Treatment of Chemotherapy-Induced Neuropathic Pain: A Pilot Study" @default.
• W2065727097 cites W141235770 @default.
• W2065727097 cites W1781345619 @default.
• W2065727097 cites W1794352460 @default.
• W2065727097 cites W1972531572 @default.
• W2065727097 cites W1976066489 @default.
• W2065727097 cites W1982526922 @default.
• W2065727097 cites W1996097254 @default.
• W2065727097 cites W2006613730 @default.
• W2065727097 cites W2014670473 @default.
• W2065727097 cites W2017809660 @default.
• W2065727097 cites W2017865504 @default.
• W2065727097 cites W2019588408 @default.
• W2065727097 cites W2021236119 @default.
• W2065727097 cites W2035889265 @default.
• W2065727097 cites W2039824535 @default.
• W2065727097 cites W2039982019 @default.
• W2065727097 cites W2057983296 @default.
• W2065727097 cites W2077725247 @default.
• W2065727097 cites W2083576051 @default.
• W2065727097 cites W2084092457 @default.
• W2065727097 cites W2085995564 @default.
• W2065727097 cites W2103289578 @default.
• W2065727097 cites W2111037078 @default.
• W2065727097 cites W2114327665 @default.
• W2065727097 cites W2141918005 @default.
• W2065727097 cites W2148937908 @default.
• W2065727097 cites W2336407319 @default.
• W2065727097 cites W4211137409 @default.
• W2065727097 cites W74237323 @default.
• W2065727097 cites W983461377 @default.
• W2065727097 doi "https://doi.org/10.1111/j.1526-4637.2007.00325.x" @default.
• W2065727097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19067834" @default.
• W2065727097 hasPublicationYear "2008" @default.
• W2065727097 type Work @default.
• W2065727097 sameAs 2065727097 @default.
• W2065727097 citedByCount "48" @default.
• W2065727097 countsByYear W20657270972012 @default.
• W2065727097 countsByYear W20657270972013 @default.
• W2065727097 countsByYear W20657270972014 @default.
• W2065727097 countsByYear W20657270972015 @default.
• W2065727097 countsByYear W20657270972016 @default.
• W2065727097 countsByYear W20657270972017 @default.
• W2065727097 countsByYear W20657270972018 @default.
• W2065727097 countsByYear W20657270972019 @default.
• W2065727097 countsByYear W20657270972020 @default.
• W2065727097 countsByYear W20657270972021 @default.
• W2065727097 countsByYear W20657270972022 @default.
• W2065727097 countsByYear W20657270972023 @default.
• W2065727097 crossrefType "journal-article" @default.
• W2065727097 hasAuthorship W2065727097A5013146986 @default.
• W2065727097 hasAuthorship W2065727097A5034903945 @default.
• W2065727097 hasAuthorship W2065727097A5035246805 @default.
• W2065727097 hasAuthorship W2065727097A5054603036 @default.
• W2065727097 hasAuthorship W2065727097A5064667083 @default.
• W2065727097 hasAuthorship W2065727097A5067076091 @default.
• W2065727097 hasAuthorship W2065727097A5068715872 @default.
• W2065727097 hasAuthorship W2065727097A5072956257 @default.
• W2065727097 hasAuthorship W2065727097A5086520966 @default.
• W2065727097 hasAuthorship W2065727097A5089910357 @default.
• W2065727097 hasBestOaLocation W20657270971 @default.
• W2065727097 hasConcept C126322002 @default.
• W2065727097 hasConcept C142724271 @default.
• W2065727097 hasConcept C197934379 @default.
• W2065727097 hasConcept C204787440 @default.
• W2065727097 hasConcept C2776608144 @default.
• W2065727097 hasConcept C2776694085 @default.
• W2065727097 hasConcept C2777107010 @default.
• W2065727097 hasConcept C2779034229 @default.
• W2065727097 hasConcept C2780820201 @default.
• W2065727097 hasConcept C42219234 @default.
• W2065727097 hasConcept C71924100 @default.
• W2065727097 hasConceptScore W2065727097C126322002 @default.
• W2065727097 hasConceptScore W2065727097C142724271 @default.
• W2065727097 hasConceptScore W2065727097C197934379 @default.
• W2065727097 hasConceptScore W2065727097C204787440 @default.
• W2065727097 hasConceptScore W2065727097C2776608144 @default.
• W2065727097 hasConceptScore W2065727097C2776694085 @default.
• W2065727097 hasConceptScore W2065727097C2777107010 @default.
• W2065727097 hasConceptScore W2065727097C2779034229 @default.
• W2065727097 hasConceptScore W2065727097C2780820201 @default.
• W2065727097 hasConceptScore W2065727097C42219234 @default.
• W2065727097 hasConceptScore W2065727097C71924100 @default.
• W2065727097 hasIssue "8" @default.

• next